Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Vomiting × Therapeutics × Clear all

Phase

Phase NA 4 Phase 3 1 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1 Substance-Related Disorders 1 Prostatic Neoplasms 1 Postoperative Nausea and Vomiting 1 Opioid-Related Disorders 1 Nausea 1 Lymphoma, Follicular 1 Colorectal Neoplasms 1

Interventions

Olanzapine 2 netupitant, palosentron drug combination 1 netupitant 1 ginger extract 1 Therapeutics 1 Palonosetron 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03631004 2022-01-13

Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients

Instituto do Cancer do Estado de São Paulo

Phase 2/3 Completed

Nausea, Vomiting, Postoperative Nausea and Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡